What Does Merck’s London Research Exit Mean for Its Current Stock Price?
If you are staring at Merck’s stock chart and wondering whether now is the moment to jump in, hold steady, or walk away, you are not alone. Merck’s recent price action has caught the eye of both long-term investors and those looking for a turnaround story. Over the last week, shares slid by 3.3%, reflecting a backdrop of pharmaceutical sector news and internal changes. Yet in the past month, there has actually been a modest gain of 2.3%, even as year-to-date performance sits at -14.6% and the stock is still down 21.2% from a year ago. The longer-term view shows some resilience, with a 32.9% return over the last five years. This reminds us that Merck has weathered plenty of market storms.
Headlines have not been kind lately,…
